BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26587792)

  • 1. DMSO Enhances TGF-β Activity by Recruiting the Type II TGF-β Receptor From Intracellular Vesicles to the Plasma Membrane.
    Huang SS; Chen CL; Huang FW; Hou WH; Huang JS
    J Cell Biochem; 2016 Jul; 117(7):1568-79. PubMed ID: 26587792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethanol Enhances TGF-β Activity by Recruiting TGF-β Receptors From Intracellular Vesicles/Lipid Rafts/Caveolae to Non-Lipid Raft Microdomains.
    Huang SS; Chen CL; Huang FW; Johnson FE; Huang JS
    J Cell Biochem; 2016 Apr; 117(4):860-71. PubMed ID: 26419316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol modulates cellular TGF-beta responsiveness by altering TGF-beta binding to TGF-beta receptors.
    Chen CL; Huang SS; Huang JS
    J Cell Physiol; 2008 Apr; 215(1):223-33. PubMed ID: 17972267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 7-Dehydrocholesterol (7-DHC), But Not Cholesterol, Causes Suppression of Canonical TGF-β Signaling and Is Likely Involved in the Development of Atherosclerotic Cardiovascular Disease (ASCVD).
    Huang SS; Liu IH; Chen CL; Chang JM; Johnson FE; Huang JS
    J Cell Biochem; 2017 Jun; 118(6):1387-1400. PubMed ID: 27862220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Betulinic acid enhances TGF-β signaling by altering TGF-β receptors partitioning between lipid-raft/caveolae and non-caveolae membrane microdomains in mink lung epithelial cells.
    Chen CL; Chen CY; Chen YP; Huang YB; Lin MW; Wu DC; Huang HT; Liu MY; Chang HW; Kao YC; Yang PH
    J Biomed Sci; 2016 Feb; 23():30. PubMed ID: 26922801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular heparan sulfate negatively modulates transforming growth factor-beta1 (TGF-beta1) responsiveness in epithelial cells.
    Chen CL; Huang SS; Huang JS
    J Biol Chem; 2006 Apr; 281(17):11506-14. PubMed ID: 16492675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholest-4-en-3-one attenuates TGF-β responsiveness by inducing TGF-β receptors degradation in Mv1Lu cells and colorectal adenocarcinoma cells.
    Chen CL; Wu DC; Liu MY; Lin MW; Huang HT; Huang YB; Chen LC; Chen YY; Chen JJ; Yang PH; Kao YC; Chen PY
    J Recept Signal Transduct Res; 2017 Apr; 37(2):189-199. PubMed ID: 27401208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells.
    Horie K; Yamashita H; Mogi A; Takenoshita S; Miyazono K
    J Cell Physiol; 1998 Jun; 175(3):305-13. PubMed ID: 9572475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF beta (transforming growth factor beta) receptor type III directs clathrin-mediated endocytosis of TGF beta receptor types I and II.
    McLean S; Di Guglielmo GM
    Biochem J; 2010 Jul; 429(1):137-45. PubMed ID: 20406198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of transforming growth factor-beta signaling by low molecular weight compounds interfering with ATP- or substrate-binding sites of the TGF beta type I receptor kinase.
    Yakymovych I; Engström U; Grimsby S; Heldin CH; Souchelnytskyi S
    Biochemistry; 2002 Sep; 41(36):11000-7. PubMed ID: 12206672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-β type II receptor.
    Wang H; Liu J; Zong Y; Xu Y; Deng W; Zhu H; Liu Y; Ma C; Huang L; Zhang L; Qin C
    Brain Res; 2010 Oct; 1357():166-74. PubMed ID: 20709030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma.
    Abou-Shady M; Baer HU; Friess H; Berberat P; Zimmermann A; Graber H; Gold LI; Korc M; Büchler MW
    Am J Surg; 1999 Mar; 177(3):209-15. PubMed ID: 10219856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sorafenib suppresses TGF-β responses by inducing caveolae/lipid raft-mediated internalization/degradation of cell-surface type II TGF-β receptors: Implications in development of effective adjunctive therapy for hepatocellular carcinoma.
    Chung CL; Wang SW; Sun WC; Shu CW; Kao YC; Shiao MS; Chen CL
    Biochem Pharmacol; 2018 Aug; 154():39-53. PubMed ID: 29678520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Construction of recombinant adenovirus vector expressing extracellular domain of TbetaR-II-RANTES fusion gene and its anti-tumor effects].
    Wang XD; Liu H; Cao S; Li H; Ren XB; Hao XS
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):405-10. PubMed ID: 17974270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mannose 6-phosphate/insulin-like growth factor-II receptor is a substrate of type V transforming growth factor-beta receptor.
    Liu Q; Grubb JH; Huang SS; Sly WS; Huang JS
    J Biol Chem; 1999 Jul; 274(28):20002-10. PubMed ID: 10391950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta receptors in verrucous and squamous cell carcinoma.
    Anderson M; Muro-Cacho C; Cordero J; Livingston S; Muñoz-Antonia T
    Arch Otolaryngol Head Neck Surg; 1999 Aug; 125(8):849-54. PubMed ID: 10448730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trichostatin A-induced TGF-beta type II receptor expression in retinoblastoma cell lines.
    Kashiwagi Y; Horie K; Kanno C; Inomata M; Imamura T; Kato M; Yamamoto T; Yamashita H
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):679-85. PubMed ID: 19737884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The spatiotemporal expression of TGF-beta1 and its receptors during periosteal chondrogenesis in vitro.
    Mizuta H; Sanyal A; Fukumoto T; Fitzsimmons JS; Matsui N; Bolander ME; Oursler MJ; O'Driscoll SW
    J Orthop Res; 2002 May; 20(3):562-74. PubMed ID: 12038632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responsiveness to transforming growth factor-beta (TGF-beta)-mediated growth inhibition is a function of membrane-bound TGF-beta type II receptor in human breast cancer cells.
    Lynch MA; Petrel TA; Song H; Knobloch TJ; Casto BC; Ramljak D; Anderson LM; DeGroff V; Stoner GD; Brueggemeier RW; Weghorst CM
    Gene Expr; 2001; 9(4-5):157-71. PubMed ID: 11444526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the functional binding sites for TGF-beta on the type II receptor leads to suppression of TGF-beta signaling.
    Shimanuki T; Hara T; Furuya T; Imamura T; Miyazono K
    Oncogene; 2007 May; 26(23):3311-20. PubMed ID: 17146441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.